Catherine Sazdanoff, Director at MERIDIAN BIOSCIENCE INC (VIVO), bought 7,700 shares at $19.20 ($148K) on 2016-04-29, disclosed to the SEC on 2016-05-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.